HSHP(HSHP)
HSHP
No analyst ratings available
No analyst price targets available for HSHP
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $196M | $182M | $182M |
| Low | $187M | $144M | $159M |
| High | $204M | $211M | $200M |
| EBITDA Avg | $164M | $152M | $152M |
| Low | $156M | $120M | $133M |
| High | $171M | $177M | $167M |
| EBIT Avg | $137M | $127M | $127M |
| Low | $131M | $100M | $111M |
| High | $143M | $148M | $140M |
| Net Income Avg | $84M | $69M | $72M |
| Low | $70M | $58M | $60M |
| High | $95M | $78M | $81M |
| EPS Avg | $1.83 | $1.50 | $1.56 |
| Low | $1.53 | $1.26 | $1.30 |
| High | $2.06 | $1.69 | $1.75 |
| Analysts (Rev / EPS) | 4 / 1 | 4 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $53M | $57M | $26M | $25M | $36M | $49M |
| Low | $52M | $55M | $25M | $24M | $35M | $48M |
| High | $55M | $58M | $26M | $25M | $36M | $50M |
| EBITDA Avg | $45M | $47M | $21M | $21M | $30M | $41M |
| Low | $43M | $46M | $21M | $20M | $29M | $40M |
| High | $46M | $49M | $22M | $21M | $30M | $42M |
| EBIT Avg | $37M | $40M | $18M | $17M | $25M | $34M |
| Low | $36M | $38M | $17M | $17M | $24M | $33M |
| High | $38M | $41M | $18M | $18M | $25M | $35M |
| Net Income Avg | $26M | $29M | $-939,697 | $-2M | $8M | $22M |
| Low | $25M | $28M | $-972,740 | $-2M | $8M | $21M |
| High | $27M | $30M | $-906,654 | $-2M | $9M | $23M |
| EPS Avg | $0.55 | $0.62 | $-0.02 | $-0.04 | $0.18 | $0.47 |
| Low | $0.53 | $0.60 | $-0.02 | $-0.04 | $0.17 | $0.45 |
| High | $0.57 | $0.64 | $-0.02 | $-0.04 | $0.19 | $0.49 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |